YOLFTbeta
CEL-SCI Corp

CEL-SCI Corp

CVM · AMEX · Healthcare / Biotechnology

1.28USD+0.09 (+7.56%)

Price History

Full chart

Market Stats

Previous Close1.19
Open1.19
Day Range1.15 – 1.28
52-Week Range0.89 – 10.83
Volume145.70K
Market Cap29.37M
P/E (TTM)0.00
Forward P/E23.04
EPS-1.69
Dividend Yield0.00%
Beta0.62
50-Day Avg1.47
200-Day Avg3.00

About

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Geert R. Kersten Esq.
  • Employees0
  • Headquarters8229 Boone Boulevard, Vienna, VA, United States, 22182, USA
  • Websitehttps://cel-sci.com

Leadership

  • Mr. Geert R. Kersten Esq.CEO, CAO,Treasurer and Director · b. 1959
  • Ms. Patricia B. PrichepChief Financial & Operations Officer, Compliance Officer & Corporate Secretary · b. 1951
  • Dr. Eyal Talor Ph.D.Chief Scientific Officer · b. 1956
  • Mr. John CiprianoSenior Vice President of Regulatory Affairs · b. 1942

Financials

Income Statement

Currency: USD1986-09-301987-09-301988-09-301989-09-301990-09-301991-09-301992-09-301993-09-301994-09-301995-09-301996-09-301997-09-301998-09-301999-09-302000-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue100.00K100.00K100.00K100.00K100.00K100.00K400.00K1.00M100.00K100.00K300.00K400.00K100.00K400.00K402.01K376.22K384.94K318.30K325.48K269.93K125.46K57.04K5.07K80.09K153.30K956.15K254.61K159.58264.03657.38K285.06K69.02K476.56K462.75K558.66K00000
Growth (%)-0.00%0.00%0.00%0.00%0.00%+300.00%+150.00%-90.00%0.00%+200.00%+33.33%-75.00%+300.00%+0.50%-6.42%+2.32%-17.31%+2.25%-17.07%-53.52%-54.53%-91.12%+1481.30%+91.40%+523.71%-73.37%-99.94%+65.45%+248878.15%-56.64%-75.79%+590.46%-2.90%+20.73%-100.00%----
Cost of Revenue1.40M900.00K---100.00K500.00K1.30M--------6.45M4.20M4.25M4.16M5.30M9.23M9.30M11.68M18.20M18.41M10.37K12.68K15.27K19.19K17.45K633.00K10.91K12.66K17.84M499.00K3.88M22.47M3.97M15.89M
Gross Profit-1.30M-800.00K100.00K100.00K100.00K--100.00K-300.00K100.00K-300.00K400.00K100.00K400.00K402.01K376.22K384.94K318.30K325.48K-125.46K57.04K5.07K80.09K153.30K956.15K244.24K-12.52K-15.00K638.19K267.61K-563.98K465.64K450.10K-17.28M-499.00K-3.88M-22.47M-3.97M-15.89M
Gross Margin-1300.00%-800.00%100.00%100.00%100.00%--25.00%-30.00%100.00%-100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-100.00%100.00%100.00%100.00%100.00%100.00%95.93%-7846.48%-5681.92%97.08%93.88%-817.13%97.71%97.26%-3093.38%-----
Operating Expense1.50M800.00K1.50M1.00M700.00K-1.30M1.80M4.70M-6.70M8.60M7.20M8.00M8.92M11.40M6.68M4.40M4.45M-5.47M9.41M9.52M12.10M18.71M18.94M17.49M19.86M27.56M34.93M25.82M20.77M17.24M20.65M11.70M35.70M32.18M9.00M22.38M8.92M
Operating Income-2.80M-1.60M-1.40M-900.00K-600.00K-800.00K-1.40M-2.10M-4.60M-3.70M-6.40M-8.20M-7.10M-7.60M-8.52M-11.03M-6.30M-4.08M-4.12M-4.08M-5.35M-9.35M-9.51M-12.02M-18.56M-17.99M-17.24M-19.87M-27.57M-34.30M-25.55M-21.34M-16.77M-20.20M-28.99M-36.19M-36.06M-31.48M-26.35M-24.81M
Operating Margin-2800.00%-1600.00%-1400.00%-900.00%-600.00%-800.00%-350.00%-210.00%-4600.00%-3700.00%-2133.33%-2050.00%-7100.00%-1900.00%-2119.08%-2931.14%-1635.54%-1282.84%-1267.27%-1511.82%-4263.77%-16395.02%-187804.40%-15008.12%-12107.14%-1881.04%-6772.26%-12450354.68%-10443552.63%-5217.18%-8964.31%-30916.13%-3519.47%-4364.11%-5188.28%-----
EBITDA-2.30M-1.50M-1.30M-800.00K-400.00K-500.00K-1.10M-2.00M-4.40M-3.60M-6.30M-7.90M-7.60M-7.30M-8.30M-10.82M-3.99M-1.65M-3.89M-2.85M-5.07M-8.00M-9.05M-40.09M9.63M-24.86M-14.68M-17.39M-27.22M-32.73M-9.08M-9.70M-16.12M-19.70M-26.83M-32.98M-31.79M-29.32M-22.21M-20.88M
EBITDA Margin-2300.00%-1500.00%-1300.00%-800.00%-400.00%-500.00%-275.00%-200.00%-4400.00%-3600.00%-2100.00%-1975.00%-7600.00%-1825.00%-2064.11%-2875.55%-1036.53%-517.59%-1194.58%-1055.55%-4044.37%-14016.80%-178640.22%-50060.43%6281.42%-2599.80%-5766.32%-10896724.53%-10309247.43%-4978.57%-3185.74%-14051.14%-3383.05%-4257.91%-4801.69%-----
Net Income-2.90M-1.70M-1.30M-1.10M-900.00K-1.20M-1.70M-2.40M-4.40M-3.90M-6.30M-8.20M-6.40M-7.50M-8.48M-10.73M-8.34M-6.37M-4.20M-3.04M-7.94M-9.63M-7.70M-40.91M10.48M-25.71M-15.48M-9.17M-27.37M-34.67M-11.47M-14.36M-31.84M-24.69M-30.28M-36.36M-36.70M-32.37M-26.92M-25.41M
Net Income Margin-2900.00%-1700.00%-1300.00%-1100.00%-900.00%-1200.00%-425.00%-240.00%-4400.00%-3900.00%-2100.00%-2050.00%-6400.00%-1875.00%-2109.00%-2853.02%-2167.16%-2001.70%-1290.32%-1126.09%-6328.23%-16881.40%-152091.12%-51078.16%6838.51%-2689.14%-6078.83%-5746927.56%-10364831.65%-5274.70%-4022.56%-20810.33%-6680.68%-5336.04%-5419.53%-----
R&D--------2.90M1.80M3.50M6.00M3.80M4.50M4.98M7.76M4.70M1.92M1.94M2.23M1.90M2.53M4.10M6.01M11.91M11.75M10.37M12.68M17.00M20.95M19.35M15.61M9.40M12.66M17.84M23.11M25.36M22.47M18.16M15.89M
R&D as % of Total Revenue--------2900.00%1800.00%1166.67%1500.00%3800.00%1125.00%1238.45%2063.21%1220.95%601.78%596.55%826.06%1512.05%4432.67%80978.54%7505.96%7770.14%1228.42%4072.38%7946515.23%6438717.19%3186.79%6788.79%22612.26%1972.55%2735.64%3193.38%-----
Interest Expense00000000000000000000000397.92K162.33K322.98K262.21K170.42K163.77K129.99K04.03M01.80M1.04M1.15M1.08M675.42K745.67K648.94K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%496.83%105.89%33.78%102.99%106794.71%62028.56%19.77%0.00%5842.06%0.00%388.43%185.39%-----

Balance Sheet

Currency: USD1986-09-301987-09-301988-09-301989-09-301990-09-301991-09-301992-09-301993-09-301994-09-301995-09-301996-09-301997-09-301998-09-301999-09-302000-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets300.00K700.00K600.00K500.00K500.00K1.60M13.80M11.60M8.10M6.40M11.90M6.30M14.40M7.60M13.81M4.51M3.77M2.92M5.51M3.09M9.65M20.73M14.68M46.03M37.80M18.63M16.07M10.84M19.23M15.45M11.60M22.92M29.59M27.62M40.54M75.87M50.52M30.53M26.99M28.16M
Total Liabilities400.00K300.00K700.00K500.00K500.00K700.00K500.00K700.00K1.40M1.60M300.00K500.00K400.00K500.00K847.42K507.73K2.71M1.69M215.98K987.31K10.58M6.06M3.85M37.19M9.95M9.55M9.04M4.14M8.79M20.68M12.55M26.26M29.59M22.49M20.81M19.34M18.36M17.31M14.12M12.20M
Total Equity-100.00K400.00K-100.00K-9.50M-10.50M900.00K13.30M10.90M6.70M4.80M11.60M5.80M14.00M7.10M12.96M4.00M1.06M1.23M5.30M2.11M-930.60K14.67M10.84M8.84M27.85M9.08M7.03M6.70M10.44M-5.23M-956.07K-3.34M9165.13M19.73M56.53M32.16M13.21M12.87M15.96M
Cash100.00K400.00K---100.00K3.20M2.20M3.40M3.90M3.50M3.50M2.80M2.70M6.91M1.78M2.08M1.75M4.26M1.96M8.08M10.99M711.26K33.57M26.57M4.26M3.94M41.61K8.51M5.73M2.92M2.37M10.31M8.44M15.51M36.06M22.67M4.15M4.74M10.95M
Total Debt--100.00K-----700.00K800.00K800.00K---24.82K31.22K1.77M873.29K3.00K3.00K3.00K-200.00K1.11M1.10M5.00M1.10M1.13M1.12M14.04M13.27M14.21M14.22M13.63M13.94M15.97M15.30M13.57M11.62M9.38M
Net Debt-100.00K-400.00K100.00K---100.00K-3.20M-2.20M-2.70M-3.10M-3.50M-3.50M-2.80M-2.70M-6.88M-1.75M-304.97K-880.02K-4.26M-1.95M-8.08M-10.99M-511.26K-32.46M-25.46M738.41K-2.84M1.09M-7.39M-4.47M10.09M11.84M3.07M5.06M-1.57M-20.09M-7.37M9.43M6.88M-1.57M

Cash Flow

Currency: USD1989-09-301990-09-301991-09-301992-09-301993-09-301994-09-301995-09-301996-09-301997-09-301998-09-301999-09-302000-09-302001-09-302002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow-500.00K-700.00K-900.00K-1.40M-2.20M-4.00M-3.50M-5.30M-5.90M-5.90M-6.30M-8.53M-8.59M-4.23M-2.54M-4.40M-3.07M-8.68M-4.89M-7.94M-6.51M-12.80M-22.56M-12.19M-13.55M-22.93M-23.83M-23.08M-13.79M-13.39M-16.32M-15.28M-18.79M-18.24M-22.85M-18.81M-17.12M
Investing Cash Flow-100.00K-200.00K-300.00K-10.30M1.10M4.20M--6.40M5.40M-6.20M-946.84K3.01M541.60K-92.60K-173.60K--90.70K-7.42M-2.52M368.72K-503.94K-318.11K-133.60K-132.76K-138.86K-93.53K-34.22K-17.00K-58.14K-335.84K-2.69M-15.18M5.49M-372.26K-108.09K-38.11K
Financing Cash Flow700.00K900.00K1.20M14.90M-800.00K2.00M11.40M500.00K14.10M100.00K13.64M446.38K3.99M2.31M7.08M917.06K14.89M15.23M183.15K39.00M6.31M565.87K12.00M9.78M31.54M21.14M20.31M13.26M21.39M14.79M25.04M54.52M-638.43K4.69M19.51M23.37M
Capital Expenditure000001.00M200.00K200.00K300.00K100.00K100.00K284.04K204.33K15.31K6.91K52.17K153.70K90.70K319.34K3.50M750.38K551.13K339.47K133.60K132.76K138.86K93.53K34.22K17.00K58.14K335.84K2.69M9.04M637.89K372.26K94.88K38.11K
Free Cash Flow-500.00K-700.00K-900.00K-1.40M-2.20M-5.00M-3.70M-5.30M-6.20M-6.00M-6.40M-8.81M-8.79M-4.25M-2.55M-4.45M-3.22M-8.77M-5.21M-11.45M-7.26M-13.36M-22.89M-12.32M-13.68M-23.07M-23.93M-23.12M-13.81M-13.45M-16.66M-17.97M-27.83M-18.88M-23.22M-18.91M-17.16M
Dividends Paid-------100.00K100.00K-------------00000-00-------
FCF to OCF100.00%100.00%100.00%100.00%100.00%125.00%105.71%100.00%105.08%101.69%101.59%103.33%102.38%100.36%100.27%101.19%105.01%101.05%106.53%144.12%111.52%104.30%101.51%101.10%100.98%100.61%100.39%100.15%100.12%100.43%102.06%117.64%148.11%103.50%101.63%100.50%100.22%
Dividend Paid to FCF--------1.89%-1.61%-------------0.00%0.00%0.00%0.00%0.00%-0.00%0.00%-------

Earnings

Report DateDec 31, 1998Mar 31, 1999Jun 30, 1999Dec 31, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Dec 31, 2000Mar 31, 2001Jun 30, 2001Mar 1, 2002May 14, 2002Aug 15, 2002Dec 31, 2002May 21, 2003Aug 15, 2003Feb 12, 2004May 12, 2004Aug 17, 2004Feb 14, 2005May 23, 2005Aug 15, 2005Feb 14, 2006May 19, 2006Aug 14, 2006Feb 15, 2007May 15, 2007Aug 14, 2007Feb 15, 2008May 16, 2008Aug 20, 2008Dec 3, 2008Feb 13, 2009May 15, 2009Aug 17, 2009Feb 16, 2010May 18, 2010Aug 17, 2010Dec 13, 2010Feb 9, 2011May 16, 2011Aug 9, 2011Dec 26, 2011Feb 9, 2012May 10, 2012Aug 9, 2012Dec 17, 2012Feb 8, 2013May 10, 2013Aug 9, 2013Dec 27, 2013Jan 2, 2014May 13, 2014Aug 8, 2014Dec 23, 2014Feb 6, 2015May 8, 2015Aug 7, 2015Dec 11, 2015Feb 9, 2016May 10, 2016Aug 9, 2016Dec 14, 2016Feb 9, 2017May 10, 2017Aug 9, 2017Dec 29, 2017Feb 12, 2018May 15, 2018Aug 14, 2018Dec 19, 2018Feb 14, 2019May 14, 2019Aug 14, 2019Dec 16, 2019Feb 10, 2020May 11, 2020Aug 10, 2020Dec 29, 2020Feb 12, 2021May 18, 2021Aug 13, 2021Dec 21, 2021Feb 11, 2022May 13, 2022Aug 12, 2022Dec 27, 2022Feb 14, 2023May 12, 2023Aug 11, 2023Dec 21, 2023Feb 14, 2024May 15, 2024Aug 14, 2024Dec 31, 2024Jan 13, 2025May 13, 2025Aug 12, 2025Dec 23, 2025Feb 12, 2026Aug 14, 2026
EPS Estimate-----------525.05-375.04-375.04---------------------------300.03-300.03-375.04---135.01-120.01--112.51-112.51-150.01-4.25-117.01-79.13-79.88-2.50-69.26-79.76-82.51--------0.00------0.12-3.00-2.70-0.15-4.50-5.70-3.00-0.15-5.70-3.90-3.00-0.19-2.70-2.70-0.20-3.00-5.10-4.50-0.16-4.20-4.20-3.90-0.10-3.30---0.00-
EPS Actual-980.24-1137.18-801.52-740.19-1135.19-794.49-681.90-932.37-1318.60-675.81-1200.12-750.08-600.06-311.57-163.59-245.77-132.00-138.37-96.24-124.34-111.47-100.71-99.71-127.35-120.00-100.60-243.68-383.89-146.98-234.40-126.68-42.36-119.73-113.96-379.56134.10-189.15-19.45-243.43-225.02-111.76-150.01-81.48-167.78-300.03-24.24-70.52-75.01-2.50-75.01-4.00-202.52-180.02-30.00-3.00-67.51-127.51-33.90-2.540.53-1.87-0.78-0.190.25-1.25-0.53-0.51-0.53-0.31-0.36-0.670.04-0.22-11.10-3.90-0.16-7.50-8.10-4.20-0.21-8.40-6.60-5.70-0.20-6.90-6.90-0.21-5.40-5.70-5.70-0.16-4.20-8.40-4.20-2.70-2.70-2.33-1.36-0.86-0.68-0.47
Surprise-----------128.57%-100.00%-60.00%--------------------------25.00%62.75%60.00%---122.23%79.80%-33.33%97.78%50.00%5.88%-73.08%-127.50%62.44%-20.00%2.53%-59.87%58.91%---------------83.33%-270.00%-44.44%-6.67%-66.67%-42.11%-40.00%-40.00%-47.37%-69.23%-90.00%-5.26%-155.56%-155.56%-5.00%-80.00%-11.76%-26.67%0.00%0.00%-100.00%-7.69%-2600.30%18.18%-----
Timing----------After-hoursAfter-hoursAfter-hours--------------------------After-hoursAfter-hoursAfter-hours--After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-Pre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursPre-market-

Key Statistics & Ratios

Market Cap29.37M
Enterprise Value30.92M
Trailing P/E0.00
Forward P/E23.04
PEG Ratio1.12
Price / Sales92.88
Price / Book2.39
EPS-1.69
Book Value0.623
Revenue (TTM)28.56K
Gross Profit (TTM)-14.80M
EBITDA-20.26M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-252.53%
Return on Assets-66.82%
Shares Outstanding17.59M
Shares Float16.93M
Beta0.62
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 12.50
  • Strong Buy
    1

Dividends

19961×
62.50Aug 28, 1996

Stock Splits

  • May 20, 20251:30
  • Jun 15, 20171:25
  • Sep 25, 20131:10
  • May 1, 19951:10